Oncology Institute Inc (TOI) Form 4 Filed by Gabriel Ling, Dec 01, 2025
SEC Form 4 · No Market Transaction
Holdings Report
This filing reports current holdings only.
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Gabriel Ling CIK 0001945281 |
Director
|
Gabriel Ling at Oncology Institute Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at Oncology Institute Inc
| 2025-11-24 | Award | — | View |
| 2025-11-20 | Gift/Other | — | View |
| 2024-11-25 | Award | — | View |
| 2023-12-28 | Award | — | View |
| 2022-11-21 | Award | — | View |
Related filings at Oncology Institute Inc
Institutional Holders
13F holders · Jun 30, 2026
119
institutional managers reporting a position
Largest by reported value
- Black Rock, Inc. $25.8M
- Deerfield Management Company, L.P. (Series C) $18.2M
- Vanguard Capital Management Llc $17.7M
5%+ Holders · 13D/G
3 filers
-
M33 Growth I L.P. 4.9%
-
Chernett Jorey 10.2%
-
Ravi Sarin 4.7%
Other insiders at Oncology Institute Inc
-
Brad Hively -$1.95M
-
Jorey Chernett +$77.9K
GET /v1/forms/4/0001553350-25-000169
API docs
View Original SEC Filing